DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

Cognitive Skills Training for Homeless Youth

Not Applicable

Completed

Conditions: Anxiety Disorders
Affective Disorders
Attention Deficit Disorder
Substance Abuse

Interventions: Behavioral: Computer Skills Training
Behavioral: Cognitive Remediation

First Posted Date: 2013-03-21

Last Posted Date: 2017-03-28

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 188

Registration Number: NCT01815398

Locations: 🇺🇸
Covenant House New York, New York City, New York, United States

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Adderall-ER
Other: Placebo
Drug: Topiramate

First Posted Date: 2013-03-15

Last Posted Date: 2019-04-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 169

Registration Number: NCT01811940

Locations: 🇺🇸
STARS, New York, New York, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Glutamatergic Modulation of Cocaine-related Deficits

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Ketamine 0.41 mg/kg
Drug: Ketamine 0.71 mg/kg
Drug: Lorazepam 2 mg

First Posted Date: 2013-02-13

Last Posted Date: 2019-04-30

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 8

Registration Number: NCT01790490

Locations: 🇺🇸
NYSPI, New York, New York, United States

Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning

Not Applicable

Completed

Conditions: Persistent Depressive Disorder

Interventions: Behavioral: Behavioral Activation for return to work

First Posted Date: 2013-02-04

Last Posted Date: 2017-06-19

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 16

Registration Number: NCT01783080

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Modafinil for Smoked Cocaine Self-Administration

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Modafinil 200 mg
Drug: Modafinil 400 mg
Drug: Modafinil 0 mg
Drug: Cocaine 0 mg
Drug: Cocaine 12 mg
Drug: Cocaine 25 mg
Drug: Cocaine 50 mg

First Posted Date: 2013-01-29

Last Posted Date: 2018-01-09

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 8

Registration Number: NCT01778010

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone

Phase 3

Completed

Conditions: Heroin Dependence

Interventions: Drug: Intranasal challenge drug

First Posted Date: 2013-01-04

Last Posted Date: 2017-09-08

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 27

Registration Number: NCT01760473

Locations: 🇺🇸
New York State Psychiatric Institute and Columbia University, New York, New York, United States

Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression

Phase 4

Completed

Conditions: Major Depression
Irritable Bowel Syndrome

Interventions: Drug: Duloxetine

First Posted Date: 2012-12-21

Last Posted Date: 2021-05-19

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 17

Registration Number: NCT01754493

Locations: 🇺🇸
New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York, United States

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Phase 4

Completed

Conditions: Depression
Suicidal Ideation

Interventions: Drug: Bupropion XL for Major Depressive Episode
Drug: Paroxetine CR for Major Depressive Episode

First Posted Date: 2012-12-13

Last Posted Date: 2017-11-21

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 15

Registration Number: NCT01748955

Locations: 🇺🇸
Columbia University/New York State Psychiatric Institute, New York, New York, United States

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

Phase 2

Completed

Conditions: Opioid Abuse
Opioid Dependence

Interventions: Drug: MN-166 (50 mg) First
Drug: Placebo First

First Posted Date: 2012-12-04

Last Posted Date: 2017-08-17

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 28

Registration Number: NCT01740414

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Kuvan in People With Schizophrenia and Schizoaffective Disorder

Phase 1

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: Kuvan
Drug: Multivitamin

First Posted Date: 2012-10-15

Last Posted Date: 2017-09-13

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 27

Registration Number: NCT01706965

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy